195 related articles for article (PubMed ID: 25736996)
1. Novel β-amyloid aggregation inhibitors possessing a turn mimic.
Hamada Y; Miyamoto N; Kiso Y
Bioorg Med Chem Lett; 2015 Apr; 25(7):1572-6. PubMed ID: 25736996
[TBL] [Abstract][Full Text] [Related]
2. Gold-nanoparticle-based multifunctional amyloid-β inhibitor against Alzheimer's disease.
Gao N; Sun H; Dong K; Ren J; Qu X
Chemistry; 2015 Jan; 21(2):829-35. PubMed ID: 25376633
[TBL] [Abstract][Full Text] [Related]
3. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
4. Combining an amyloid-beta (Aβ) cleaving enzyme inhibitor with a γ-secretase modulator results in an additive reduction of Aβ production.
Strömberg K; Eketjäll S; Georgievska B; Tunblad K; Eliason K; Olsson F; Radesäter AC; Klintenberg R; Arvidsson PI; von Berg S; Fälting J; Cowburn RF; Dabrowski M
FEBS J; 2015 Jan; 282(1):65-73. PubMed ID: 25303711
[TBL] [Abstract][Full Text] [Related]
5. Peptides, Peptidomimetics, and Carbohydrate-Peptide Conjugates as Amyloidogenic Aggregation Inhibitors for Alzheimer's Disease.
Ryan P; Patel B; Makwana V; Jadhav HR; Kiefel M; Davey A; Reekie TA; Rudrawar S; Kassiou M
ACS Chem Neurosci; 2018 Jul; 9(7):1530-1551. PubMed ID: 29782794
[TBL] [Abstract][Full Text] [Related]
6. Phytomedicines as potential inhibitors of β amyloid aggregation: significance to Alzheimer's disease.
Kumar NS; Nisha N
Chin J Nat Med; 2014 Nov; 12(11):801-18. PubMed ID: 25480511
[TBL] [Abstract][Full Text] [Related]
7. Graphene quantum dots for the inhibition of β amyloid aggregation.
Liu Y; Xu LP; Dai W; Dong H; Wen Y; Zhang X
Nanoscale; 2015 Dec; 7(45):19060-5. PubMed ID: 26515666
[TBL] [Abstract][Full Text] [Related]
8. Rationally Designed Peptides and Peptidomimetics as Inhibitors of Amyloid-β (Aβ) Aggregation: Potential Therapeutics of Alzheimer's Disease.
Goyal D; Shuaib S; Mann S; Goyal B
ACS Comb Sci; 2017 Feb; 19(2):55-80. PubMed ID: 28045249
[TBL] [Abstract][Full Text] [Related]
9. Amyloid-β protein (Aβ) Glu11 is the major β-secretase site of β-site amyloid-β precursor protein-cleaving enzyme 1(BACE1), and shifting the cleavage site to Aβ Asp1 contributes to Alzheimer pathogenesis.
Deng Y; Wang Z; Wang R; Zhang X; Zhang S; Wu Y; Staufenbiel M; Cai F; Song W
Eur J Neurosci; 2013 Jun; 37(12):1962-9. PubMed ID: 23773065
[TBL] [Abstract][Full Text] [Related]
10. A cyclic KLVFF-derived peptide aggregation inhibitor induces the formation of less-toxic off-pathway amyloid-β oligomers.
Arai T; Sasaki D; Araya T; Sato T; Sohma Y; Kanai M
Chembiochem; 2014 Nov; 15(17):2577-83. PubMed ID: 25262917
[TBL] [Abstract][Full Text] [Related]
11. β-sheet interfering molecules acting against β-amyloid aggregation and fibrillogenesis.
Francioso A; Punzi P; Boffi A; Lori C; Martire S; Giordano C; D'Erme M; Mosca L
Bioorg Med Chem; 2015 Apr; 23(8):1671-83. PubMed ID: 25769517
[TBL] [Abstract][Full Text] [Related]
12. Development of retro-inverso peptides as anti-aggregation drugs for β-amyloid in Alzheimer's disease.
Matharu B; El-Agnaf O; Razvi A; Austen BM
Peptides; 2010 Oct; 31(10):1866-72. PubMed ID: 20633587
[TBL] [Abstract][Full Text] [Related]
13. The heterogeneous nature of Cu2+ interactions with Alzheimer's amyloid-β peptide.
Drew SC; Barnham KJ
Acc Chem Res; 2011 Nov; 44(11):1146-55. PubMed ID: 21714485
[TBL] [Abstract][Full Text] [Related]
14. Non-toxic conformer of amyloid β may suppress amyloid β-induced toxicity in rat primary neurons: implications for a novel therapeutic strategy for Alzheimer's disease.
Izuo N; Murakami K; Sato M; Iwasaki M; Izumi Y; Shimizu T; Akaike A; Irie K; Kume T
Biochem Biophys Res Commun; 2013 Aug; 438(1):1-5. PubMed ID: 23747423
[TBL] [Abstract][Full Text] [Related]
15. [Therapy of Alzheimer disease].
Kovács T
Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
[TBL] [Abstract][Full Text] [Related]
16. Dual inhibition of BACE1 and Aβ aggregation by β-ecdysone: Application of a phytoecdysteroid scaffold in Alzheimer's disease therapeutics.
Chakraborty S; Basu S
Int J Biol Macromol; 2017 Feb; 95():281-287. PubMed ID: 27871792
[TBL] [Abstract][Full Text] [Related]
17. Covalent modifier-type aggregation inhibitor of amyloid-β based on a cyclo-KLVFF motif.
Kino R; Araya T; Arai T; Sohma Y; Kanai M
Bioorg Med Chem Lett; 2015 Aug; 25(15):2972-5. PubMed ID: 26045033
[TBL] [Abstract][Full Text] [Related]
18. Molecular dynamics simulations of Aβ fibril interactions with β-sheet breaker peptides.
Bruce NJ; Chen D; Dastidar SG; Marks GE; Schein CH; Bryce RA
Peptides; 2010 Nov; 31(11):2100-8. PubMed ID: 20691234
[TBL] [Abstract][Full Text] [Related]
19. Effect of Tong Luo Jiu Nao on Aβ-degrading enzymes in AD rat brains.
Liu Y; Hua Q; Lei H; Li P
J Ethnopharmacol; 2011 Sep; 137(2):1035-46. PubMed ID: 21798326
[TBL] [Abstract][Full Text] [Related]
20. Perspectives on Inhibiting β-Amyloid Aggregation through Structure-Based Drug Design.
Mishra P; Ayyannan SR; Panda G
ChemMedChem; 2015 Sep; 10(9):1467-74. PubMed ID: 26230674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
